← Open Payments lookup

AUBREY BODILY: Open Payments

NPI 1538701529 · NAMPA, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$942 in 65 payments from 14 companies in 2025. Trend: 2023 $912 · 2024 $665 · 2025 $942

Food & beverage: $942
CompanyPaymentsAmount
ABBVIE INC.30$251
Alkermes, Inc.10$185
Janssen Pharmaceuticals, Inc4$92
Teva Pharmaceuticals USA, Inc.3$86
Vanda Pharmaceuticals Inc.4$81
Otsuka America Pharmaceutical, Inc.4$68
E.R. Squibb & Sons, L.L.C.2$34
Corium, LLC2$24
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$23
Neurocrine BioSciences, Inc.1$21

Products named: VRAYLAR, ARISTADA, INVEGA SUSTENNA, AUSTEDO XR, FANAPT, LYBALVI, ABILIFY ASIMTUFII, REXULTI.

Industry payments across ID — which companies pay providers there.